MiniMed Group Inc (MMED)

Currency in USD
18.15
+0.01(+0.03%)
Real-time Data·
MMED is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
17.6618.24
52 wk Range
10.6520.48
Key Statistics
Prev. Close
18.15
Open
18.15
Day's Range
17.66-18.24
52 wk Range
10.65-20.48
Volume
229.87K
Average Volume (3m)
1.03M
1-Year Change
-
Book Value / Share
12.86
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MMED Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
21.00
Upside
+15.70%
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week

MiniMed Group Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Strong Buy

Analyst Ratings

11 Buy
1 Hold
0 Sell
Ratings:
12 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 21.00
(+15.70% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
UBS
Buy25.00+37.59%-New CoverageJul 29, 2026
Benchmark
Buy20.00+10.07%20.00MaintainJul 08, 2026
Benchmark
Buy20.00+10.07%-MaintainJun 12, 2026
Benchmark
Buy20.00+10.07%20.00MaintainJun 04, 2026
Piper Sandler
Hold16.00-11.94%-MaintainJun 04, 2026

MiniMed Group Inc Earnings Call Summary for Q4/2026

  • Q4 revenue hit $837M with 8.7% organic growth; full-year revenue exceeded $3B for first time, driven by 12.2% international growth.
  • Adjusted EBITDA surged 32% to $154M in Q4; margins expanded 220 bps to 18.4%, reflecting significant profitability improvements.
  • Stock jumped 2.44% premarket, trading at $12.60; analysts rate strong buy with price targets of $16-$26, suggesting major upside potential.
  • U.S. growth lagged at 1.5% due to early FDA clearance timing for MiniMed Flex; company plans sensor integration and patch pump launches.
  • FY2027 guidance projects Q4 revenue of $903.54M and EPS of $0.23; analysts expect profitability turn with net income growth anticipated.
Last Updated: 2026-06-03, 09:50 a/m
Read Full Transcript

Earnings

Latest Release
Jun 03, 2026
EPS / Forecast
-0.68 / 0.16
Revenue / Forecast
837M / 770.87M
EPS Revisions
Last 90 days

MMED Income Statement

Compare MMED to Peers and Sector

Metrics to compare
MMED
Peers
Sector
Relationship
P/E Ratio
−15.1x−2.7x−0.3x
PEG Ratio
0.280.240.00
Price/Book
1.4x2.0x2.6x
Price / LTM Sales
1.6x2.4x3.0x
Upside (Analyst Target)
10.2%33.3%56.6%
Fair Value Upside
Unlock2.1%10.2%Unlock

MiniMed Group, Inc. operates as a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company offers technologies including insulin delivery devices, such as insulin pumps and pens, continuous glucose monitors, other consumables, supplies, and related software and services. It serves people with diabetes who require insulin therapy, which represents all people with T1D and a subset of those with T2D. The company’s platform includes Automated Insulin Delivery (AID) systems for glucose sensing and automated insulin dosing and administration for glycemic control and Smart Multiple Daily Injection (MDI) systems for self-administering insulin by manual injections, which include InPen, Simplera Sync, or Guardian 4 sensor, and wraparound applications and services. It also offers CareLink, a software platform that provides support for person with diabetes, their caretakers, and HCPS. MiniMed Group, Inc. was founded in 1983 and is headquartered in Northridge, California. MiniMed Group, Inc. operates as a subsidiary of Medtronic plc.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
10.30M3.67%189.49M
Other Institutional Investors
276.06M96.33%5.08B
Public Companies & Retail Investors
0.000.00%0.00
Total
286.36M100.00%5.27B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Medtronic plc90.02%252,813,3484,651,766
Massachusetts Financial Services Company2.45%6,878,460126,564

People Also Watch

15.13
PAYP
-5.97%
13.03
PICS
+1.01%
10.84
MH
+0.18%
37.84
RAMP
+0.13%

FAQ

What Is the MiniMed (MMED) Stock Price Today?

The MiniMed stock price today is 18.15 USD.

What Stock Exchange Does MiniMed Trade On?

MiniMed is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for MiniMed?

The stock symbol for MiniMed is "MMED."

What Is the MiniMed Market Cap?

As of today, MiniMed market cap is 5.10B USD.

What Is MiniMed's Earnings Per Share (TTM)?

The MiniMed EPS (TTM) is -1.30.

When Is the Next MiniMed Earnings Date?

MiniMed will release its next earnings report on Sep 30, 2026.

From a Technical Analysis Perspective, Is MMED a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has MiniMed Stock Split?

MiniMed has split 0 times.

How Many Employees Does MiniMed Have?

MiniMed has 8000 employees.

What is the current trading status of MiniMed (MMED)?

As of Jul 31, 2026, MiniMed (MMED) is trading at a price of 18.15 USD, with a previous close of 18.15 USD. The stock has fluctuated within a day range of 17.66 USD to 18.24 USD, while its 52-week range spans from 10.65 USD to 20.48 USD.

What Is MiniMed (MMED) Price Target According to Analysts?

The average 12-month price target for MiniMed is 21.00 USD, with a high estimate of 25 USD and a low estimate of 16 USD. 11 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +15.70% Upside potential.

What Is the MMED After Hours Price?

MMED's last after hours stock price is 18.01 USD, the stock has decreased by -0.14, or -0.74%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.